A small interfering RNA targeting proteinase‐activated receptor‐2 is effective in suppression of tumor growth in a Panc1 xenograft model
Authors:
Open Access
- 26 November 2007
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 122 (3) , 658-663
Abstract
Proteinase‐activated receptor‐2 (PAR‐2), which is a G protein‐coupled receptor, is activated in inflammatory processes and cell proliferation. We previously demonstrated that an anti‐PAR‐2 antibody suppresses proliferation of human pancreatic cellsin vitro. However, there have been no studies of PAR‐2 signaling pathwaysin vivo. The aim of this study was to determine whether blockade of PAR‐2 by RNA interference influences pancreatic tumor growth. We originally constructed small interfering RNAs (siRNAs) targeting humanPAR‐2, and performed cell proliferation assays of Panc1 human pancreatic cancer cell line with these siRNAs. Intratumoral treatment with these PAR‐2 siRNAs and atelocollagen was also performed in a xenograft model with nude mice and Panc1 cells. siRNAs against humanPAR‐2inhibited proliferation of Panc1 cells, whereas control scramble siRNAs had no effect on proliferation. The PAR‐2 siRNAs dramatically suppressed tumor growth in the xenograft model. PAR‐2‐specific siRNA inhibited growth of human pancreatic cancer cells bothin vitroandin vivo. Blockade of PAR‐2 signaling by siRNA may be a novel strategy to treat pancreatic cancer.Keywords
This publication has 48 references indexed in Scilit:
- Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB-231 cells via MAPK pathwaysBiochemical and Biophysical Research Communications, 2006
- Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancerJournal of Clinical Pathology, 2006
- Protease-Activated Receptor-2-Mediated Proliferation and Collagen Production of Rat Pancreatic Stellate CellsThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Unlocking the potential of the human genome with RNA interferenceNature, 2004
- Amplification of MMP‐2 and MMP‐9 production by prostate cancer cell lines via activation of protease‐activated receptorsThe Prostate, 2004
- Induction of an interferon response by RNAi vectors in mammalian cellsNature Genetics, 2003
- Expression profiling reveals off-target gene regulation by RNAiNature Biotechnology, 2003
- Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancerThe Journal of Pathology, 2003
- Trypsin is produced by and activates protease-activated receptor-2 in human cancer colon cellsLife Sciences, 2002
- Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activationCell, 1991